Zentalis Pharmaceuticals, LLC – Trademark Portfolio
Entity Type: 16
Zentalis Pharmaceuticals, LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ZENTALIS. The owner is based in San Diego, CA.
10835 Road to the Cure, Suite 205
San Diego, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
Zentalis Pharmaceuticals, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Zentalis Pharmaceuticals, LLC have?
Zentalis Pharmaceuticals, LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Zentalis Pharmaceuticals, LLC file in?
Zentalis Pharmaceuticals, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Zentalis Pharmaceuticals, LLC's most well-known trademarks?
Zentalis Pharmaceuticals, LLC's registered trademark portfolio includes well-known marks such as ZENTALIS. These are among 1 currently registered trademark in the portfolio.
What is Zentalis Pharmaceuticals, LLC's trademark registration success rate?
Zentalis Pharmaceuticals, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.